A Study to Investigate the Pharmacokinetics and Safety of Risdiplam in Infants With Spinal Muscular Atrophy

NCT05808764 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

10

Enrollment

INDUSTRY

Sponsor class

Conditions

Muscular Atrophy, Spinal

Interventions

DRUG: Risdiplam

Sponsor

Hoffmann-La Roche